Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) and Ipilimumab Intravenous
Determining the interaction of Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight) and Ipilimumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: ipilimumab
Brand name: Yervoy
Synonyms: Ipilimumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-IPlex
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Ipol
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Ipratropium
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Ipratropium (Oral Inhalation)
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Ipratropium and Albuterol
- Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)-Ipratropium and Albuterol Inhalation Solution
- Ipilimumab Intravenous-Antihemophilic Factor (Recombinant) (Nuwiq)
- Ipilimumab Intravenous-Antihemophilic Factor (Recombinant) (Recombinate)
- Ipilimumab Intravenous-Antihemophilic Factor (Recombinant) (Xyntha)
- Ipilimumab Intravenous-Antihemophilic factor (recombinant) pegylated-aucl Intravenous
- Ipilimumab Intravenous-Antihemophilic factor (recombinant) porcine sequence Intravenous
- Ipilimumab Intravenous-Antihemophilic factor human